Home/Pipeline/StrivePD Care Ecosystem

StrivePD Care Ecosystem

Parkinson's Disease

CommercialActive

Key Facts

Indication

Parkinson's Disease

Phase

Commercial

Status

Active

Company

Rune Labs

About Rune Labs

Rune Labs is a private, San Francisco-based digital health company founded in 2018, operating at the intersection of neuroscience, AI, and data analytics. Its core offering is the StrivePD ecosystem, an FDA-cleared platform that uses the Apple Watch to collect Parkinson's symptom data, enabling personalized patient care and providing real-world datasets for clinical research. The company generates revenue by offering its StriveStudy platform and data services to life sciences companies for clinical trials, real-world evidence, and commercial support, while also serving clinicians and patients directly. Rune Labs has established key partnerships with healthcare providers like Kaiser Permanente and biotech firms like BlueRock Therapeutics.

View full company profile

Therapeutic Areas

Parkinson's Disease Multiple Sclerosis Obsessive-Compulsive Disorder Essential Tremor

Other Parkinson's Disease Drugs

Drug	Company	Phase	Status
NPT200-11	Neuropore Therapies	Phase 1	Partnered (UCB Pharma), status unclear
NUZ-001	Neurizon Therapeutics	Preclinical	Active
VXX-301	Vaxxinity	Preclinical	Pipeline
BAN2802	BioArctic	Phase 1	Active
CNM-Au8	Clene	Phase 2	Active
hpSC-Derived Neural/Dopaminergic Cells	International Stem Cell	Preclinical/Early Clinical	Inferred Active
SLS-004	Seelos Therapeutics	Preclinical	Research
SLS-007	Seelos Therapeutics	Preclinical	Research
Parkinson's Disease Portfolio (Platform-derived)	WD Pharmaceutical	Not Disclosed (Likely Preclinical/Early Clinical)	Active
UX-DA001	UniXell	Phase 1	Active, with trials ongoing in China and FDA IND cleared in U.S. (as of April 2025)
Parkinson's Disease Research	ProgenaBiome	Research	Active
A9 Dopaminergic Neuron Therapy	Trailhead Biosystems	Pre-clinical	Active